Breaking News Instant updates and real-time market news.

FL

Foot Locker

$46.10

(0.00%)

09:42
11/21/18
11/21
09:42
11/21/18
09:42

Technical Take: Foot Locker slips from earlier highs

The shares were last at $52.93, up over 14.8% on the day but off the earlier high of $53.96 which is now resistance. Support is at the current session low at $52.38 and then at $51.64.

FL Foot Locker
$46.10

(0.00%)

11/21/18
WELS
11/21/18
NO CHANGE
Target $64
WELS
Outperform
Foot Locker price target raised to $64 from $58 at Wells Fargo
Wells Fargo analyst Tom Nikic raised his price target for Foot Locker (FL) to $64 from $58 and reiterated an Outperform rating on the shares. The analyst believes Foot Locker's turnaround story continues to pick up steam, as he thinks the Q3 print alleviated many of the concerns that have weighed on the shares this year. Nikic continues to view Foot Locker as a "very compelling turnaround story," driven by improving product flows, strong relationships with their key vendors such as Nike (NKE), a capable management team that has shown an ability to quickly adapt to changing market conditions, and a stock that is still fairly inexpensive.
11/21/18
JEFF
11/21/18
NO CHANGE
Target $62
JEFF
Buy
Jefferies says Foot Locker 'back on its feet,' boosts target to $62
Jefferies analyst Janine Stichter proclaims Foot Locker is "back on its feet" after the company reported upside in Q3 to both sales and margins. The analyst sees a case for both earnings upside and multiple expansion as "confidence in the top-line sustainability is restored." She raised her price target for Foot Locker shares to $62 from $60 and keeps a Buy rating on the name Foot Locker remains Stichter's favorite way to play Nike's (NKE) resurgence in North America.
11/21/18
ADAM
11/21/18
NO CHANGE
Target $64
ADAM
Buy
Foot Locker recovery thesis playing out, says Canaccord
Canaccord analyst Camilo Lyon noted Foot Locker reported solid Q3 results and said the beat was high quality. He was particularly pleased with the inflection in footwear and Europe as it benefited from the breadth and depth of on-trend platforms that resulted in an improving inventory mix. Lyon believes the results show his recovery thesis is playing out. He reiterated his Buy rating and raised his price target to $64 from $63 on Foot Locker shares.
11/21/18
FBCO
11/21/18
NO CHANGE
Target $63
FBCO
Outperform
Foot Locker price target raised to $63 from $56 at Credit Suisse
Credit Suisse analyst Michael Binetti raised his price target for Foot Locker (FL) to $63 from $56 following quarterly results as he believes the company proved out the accelerating same-store sales story. The analyst thinks Q3 goes a long way to proving Foot Locker can comp alongside Nike's (NKE) DTC aspirations. Binetti reiterates an Outperform rating on Foot Locker's shares.

TODAY'S FREE FLY STORIES

ENR

Energizer

$46.15

0.915 (2.02%)

06:14
03/22/19
03/22
06:14
03/22/19
06:14
Initiation
Energizer initiated  »

Energizer initiated with…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NKE

Nike

$88.05

1.3597 (1.57%)

06:10
03/22/19
03/22
06:10
03/22/19
06:10
Recommendations
Nike analyst commentary  »

Nike investments paying…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 04

    Apr

  • 04

    Apr

BRN

Barnwell Industries

$1.30

(0.00%)

06:10
03/22/19
03/22
06:10
03/22/19
06:10
Hot Stocks
Barnwell Industries announces real estate transaction through KD »

Barnwell Industries…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

STX

Seagate

$48.95

2.73 (5.91%)

, HPE

HP Enterprise

$16.03

0.15 (0.94%)

06:09
03/22/19
03/22
06:09
03/22/19
06:09
Periodicals
Seagate teams up with HPE, Nvidia for Project Athena, DigiTimes reports »

Seagate (STX) has…

STX

Seagate

$48.95

2.73 (5.91%)

HPE

HP Enterprise

$16.03

0.15 (0.94%)

NVDA

Nvidia

$183.92

9.54 (5.47%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Mar

  • 03

    Apr

ESALY

Eisai

$0.00

(0.00%)

06:06
03/22/19
03/22
06:06
03/22/19
06:06
Downgrade
Eisai rating change  »

Eisai downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CVA

Covanta

$17.04

0.27 (1.61%)

06:05
03/22/19
03/22
06:05
03/22/19
06:05
Hot Stocks
Covanta, Green Investment Group reach financial close on Rookery project »

Covanta and Green…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Mar

GBX

Greenbrier

$37.33

0.45 (1.22%)

06:05
03/22/19
03/22
06:05
03/22/19
06:05
Earnings
Greenbrier reports preliminary Q2 EPS 7c-9c, consensus 42c »

Reports preliminary Q2…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FB

Facebook

$166.08

0.61 (0.37%)

06:05
03/22/19
03/22
06:05
03/22/19
06:05
Periodicals
Facebook knew about data misuse earlier than reported, Guardian says »

Facebook knew about…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Mar

  • 03

    Apr

  • 04

    Apr

NKE

Nike

$88.05

1.3597 (1.57%)

06:04
03/22/19
03/22
06:04
03/22/19
06:04
Recommendations
Nike analyst commentary  »

Nike price target raised…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 04

    Apr

  • 04

    Apr

GTLS

Chart Industries

$94.49

2.06 (2.23%)

, BHGE

Baker Hughes

$28.50

0.24 (0.85%)

06:03
03/22/19
03/22
06:03
03/22/19
06:03
Hot Stocks
Chart Industries books $135M order »

Chart Industries (GTLS)…

GTLS

Chart Industries

$94.49

2.06 (2.23%)

BHGE

Baker Hughes

$28.50

0.24 (0.85%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Apr

  • 22

    May

  • 28

    May

  • 28

    May

AAPL

Apple

$195.07

6.93 (3.68%)

06:01
03/22/19
03/22
06:01
03/22/19
06:01
Periodicals
Apple signs Vox to be part of news subscription service, Bloomberg reports »

Apple has signed Vox to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Mar

LIND

Lindblad Expeditions

$15.18

-0.12 (-0.78%)

05:55
03/22/19
03/22
05:55
03/22/19
05:55
Conference/Events
Lindblad Expeditions management to meet with Sidoti »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Mar

DRI

Darden

$116.11

7.485 (6.89%)

05:53
03/22/19
03/22
05:53
03/22/19
05:53
Recommendations
Darden analyst commentary  »

Darden price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CMC

Commercial Metals

$17.35

1.29 (8.03%)

05:43
03/22/19
03/22
05:43
03/22/19
05:43
Upgrade
Commercial Metals rating change  »

Commercial Metals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SWK

Stanley Black & Decker

$134.59

2.69 (2.04%)

05:42
03/22/19
03/22
05:42
03/22/19
05:42
Upgrade
Stanley Black & Decker rating change  »

Stanley Black &…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Apr

  • 24

    Apr

BIIB

Biogen

$226.71

-93.76 (-29.26%)

05:42
03/22/19
03/22
05:42
03/22/19
05:42
Downgrade
Biogen rating change  »

Biogen downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Mar

  • 24

    Apr

  • 30

    Apr

  • 01

    May

  • 28

    May

BBY

Best Buy

$70.56

1.44 (2.08%)

05:41
03/22/19
03/22
05:41
03/22/19
05:41
Upgrade
Best Buy rating change  »

Best Buy upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

VAR

Varian Medical

$137.77

1.97 (1.45%)

05:41
03/22/19
03/22
05:41
03/22/19
05:41
Upgrade
Varian Medical rating change  »

Varian Medical upgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Apr

BIIB

Biogen

$226.71

-93.76 (-29.26%)

05:41
03/22/19
03/22
05:41
03/22/19
05:41
Downgrade
Biogen rating change at Citi »

Citi downgrades Biogen to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Mar

  • 24

    Apr

  • 30

    Apr

  • 01

    May

  • 28

    May

FTI

TechnipFMC

$23.83

0.09 (0.38%)

05:40
03/22/19
03/22
05:40
03/22/19
05:40
Upgrade
TechnipFMC rating change  »

TechnipFMC upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Apr

RYB

RYB Education

$8.01

0.09 (1.14%)

05:40
03/22/19
03/22
05:40
03/22/19
05:40
Downgrade
RYB Education rating change  »

RYB Education downgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LOV

Spark Networks

$11.29

(0.00%)

05:26
03/22/19
03/22
05:26
03/22/19
05:26
Conference/Events
Spark Networks to host conference call »

Conference call to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Mar

ESALY

Eisai

$0.00

(0.00%)

05:25
03/22/19
03/22
05:25
03/22/19
05:25
Downgrade
Eisai rating change  »

Eisai downgraded to Sell…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ESALY

Eisai

$0.00

(0.00%)

, BIIB

Biogen

$226.71

-93.76 (-29.26%)

05:24
03/22/19
03/22
05:24
03/22/19
05:24
Hot Stocks
Eisai announces initiation of Phase III BAN2401 study in Alzheimer's disease »

Eisai (ESALY) announced…

ESALY

Eisai

$0.00

(0.00%)

BIIB

Biogen

$226.71

-93.76 (-29.26%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Mar

  • 24

    Apr

  • 30

    Apr

  • 01

    May

  • 28

    May

ZUO

Zuora

$24.34

0.62 (2.61%)

05:18
03/22/19
03/22
05:18
03/22/19
05:18
Recommendations
Zuora analyst commentary at Jefferies »

Zuora business metrics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Apr

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.